Nuzenio

Biaf

Biaf news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 7 publisher sources 100/100 entity strength

Latest news

bioAffinity Technologies, Inc. Q2 2026: Revenue $1.51M, EPS $(0.64) — 10-Q Summary - TradingViewTradingView · Fri, 07 Aug 2026 20:51:12 GMTBIAF: Strong CyPath® Lung growth drives Q2 2026, but liquidity concerns persist amid ongoing losses - TradingViewTradingView · Fri, 07 Aug 2026 20:49:59 GMTBIAF: Q2 2026 saw 216% CyPath Lung test growth and 19% revenue increase, with improved net loss - TradingViewTradingView · Fri, 07 Aug 2026 12:36:27 GMTbioAffinity Technologies reports Q2 2026 revenue $1.51M, net loss $3.37M, cash $2.43M - TradingViewTradingView · Fri, 07 Aug 2026 12:33:01 GMTPhysician offices ordering bioAffinity's lung test rose 122% in Q2 - Stock TitanStock Titan · Fri, 07 Aug 2026 12:00:00 GMTPress Release: BioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath(R) Lung - MoomooMoomoo · Fri, 07 Aug 2026 12:00:00 GMTbioAffinity Technologies Inc (BIAF) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 08:23:49 GMTTheatre, films and performances for one month at BIAF; special guest - actor George Mihaita - AgerpresAgerpres · Fri, 07 Aug 2026 06:26:17 GMT

Timeline

Fri, 07 Aug 2026 20:51:12 GMTbioAffinity Technologies, Inc. Q2 2026: Revenue $1.51M, EPS $(0.64) — 10-Q Summary - TradingView
Fri, 07 Aug 2026 20:49:59 GMTBIAF: Strong CyPath® Lung growth drives Q2 2026, but liquidity concerns persist amid ongoing losses - TradingView
Fri, 07 Aug 2026 12:36:27 GMTBIAF: Q2 2026 saw 216% CyPath Lung test growth and 19% revenue increase, with improved net loss - TradingView
Fri, 07 Aug 2026 12:33:01 GMTbioAffinity Technologies reports Q2 2026 revenue $1.51M, net loss $3.37M, cash $2.43M - TradingView
Fri, 07 Aug 2026 12:00:00 GMTPhysician offices ordering bioAffinity's lung test rose 122% in Q2 - Stock Titan
Fri, 07 Aug 2026 12:00:00 GMTPress Release: BioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath(R) Lung - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Biaf.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.